Surgery Godfather-Chapter 441 - 403 - Deal Made_3

Chapter 441: Chapter 403 – Deal Made_3

Chapter 441: Chapter 403 – Deal Made_3

After a brief blush, Solin immediately said, “No, you cannot see it that way. If we cannot work together, the value of these patents will not be realized. If you return to China, these patents will be greatly cheapened, even left unused. The inner core in this curved drill bit cannot feasibly be manufactured given China’s processing skill level.”

Foll𝑜w current novels on fɾēewebnσveℓ.com.

His statement truly hit a sore spot. Because the inner core required high precision, domestic manufacturers were unable to process it. It was this fear of waste that led Yang Ping to be willing to authorize its use to the Americans, otherwise, he would have cooperated with a domestic manufacturer long ago.

Helpless, he had tried to cooperate with domestic manufacturers but they would only offer several hundred thousand and were lackadaisical about it.

So, Yang Ping planned to sell to an American company to first earn a sum of money. Then, he could make other plans.

For this set of instrumentation’s technical route, he had also identified alternatives. If one day, a domestic manufacturer was willing to cooperate in manufacturing, he could redesign an upgraded version avoiding his own patents.

“Mr. Solin, you are wrong. The market for orthopedic consumables for children is currently a blue ocean. However, Stryker, Shi Lehui, Johnson & Johnson, and all other giants have begun to lay out their strategies. You are all in jeopardy yet oblivious. I find your dullness surprising. I won’t hide from you that your company is not the only one interested in our equipment. Because it is a trade secret, I cannot disclose more information, but I should kindly remind you, these giants, no matter who gets authorization for our equipment, it will be a heavy blow to OrthoPediatricS.”

Huang Jiacai placed the ticket for his trip to Stryker’s headquarters in Kalamazoo, Michigan, on the office desk.

“This is my ticket to Kalamazoo a few days ago. The purpose of my trip is self-explanatory, a trade secret. We are still negotiating with you because you are focused on orthopedic implants for children and can do a better job than others at maximizing the value of the equipment. It’s a pity that you can’t recognize their worth. In that case, we have to go for the next best option. Allow me to tell Mr. Solin some information. One, we are not short on money. If you look into Doctor Yang’s surgery commission, you can verify this info. Two, our friends in Kalamazoo are more discerning than you. Our negotiations with you, in our Chinese terms, contain a hint of sentiment.”

Huang Jiacai’s speech was full of ups and downs, neither hurried nor slow, thinking: Lawyers and patent commissioners are sitting opposite. This is a formal team, and the board of directors does not hold a meeting without sending such a team. It seems that the foreigners are anxious and treat us like rookies.

Old Cheng looked at the ticket on the table, completely baffled, thinking: This kid, he went to inspect, when did he go to negotiate patent matters? His ability to bluff, speaking without blushing, as if everything he said was true.

If it were not for Old Cheng knowing his situation, he would really think he was telling the truth.

“An exclusive annual license fee of 20 million US dollars payable annually. Keep in mind, for other manufacturers, we require a five-year payment. If you agree, we will sign the contract today. If you disagree, we have no need to talk further.”

Huang Jiacai put the ticket back on the office desk.

Solin stood up: “Wait, let me make a phone call. Give me ten minutes.”

After ten minutes, Solin returned: “Deal!”

“Deal!” Huang Jiacai shook hands with him.

The equipment set is readily available, and one could start production with the blueprints, opening up a new market. This is essentially a cash cow. The cost was within the price range that the OrthoPediatricS company could accept psychologically.

When Solin reported back to his company, the CEO immediately replied: Go for it!

The company’s board of directors had already discussed the trade price and drawn a range.